A Win For Iterum Therapeutics plc
Tue, Oct 20, 2020 at 05:30 PM
Iterum Therapeutics plc (ITRM:NASDAQ) shot up at $1.15, a gain of 35.3%. On Mon 19 Oct 20, ITRM:NASDAQ touched a New 2-Week Low of $0.85. The stock appeared on our News Catalysts scanner on Tue 20 Oct 20 at 04:46 AM in the 'BIOTECH' category. From Mon 05 Oct 20, the stock recorded 20.00% Up Days and 36.36% Green Days
The stock spiked on Fri 09 Oct 20 at $1.1 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About Iterum Therapeutics plc (ITRM:NASDAQ)
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Top 10 Gainers:
- Weidai Ltd. (WEI:NYSE), 526.45%
- X Financial (XYF:NYSE), 75.88%
- Dragon Victory International Limited (LYL:NASDAQ), 47.64%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 46.08%
- Jupai Holdings Limited (JP:NYSE), 42.69%
- Molecular Data Inc. (MKD:NASDAQ), 41.82%
- Acorda Therapeutics, Inc. (ACOR:NASDAQ), 39.42%
- China Index Holdings Limited (CIH:NASDAQ), 35.71%
- Iterum Therapeutics plc (ITRM:NASDAQ), 35.29%
- Drive Shack Inc. (DS:NYSE), 31.62%